The Latin America, Middle East and Africa Iliac Stent Market would witness market growth of 8.7% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA Iliac Stent Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $26.7 million by 2030. The Argentina market is showcasing a CAGR of 9.4% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 8.4% during (2023 - 2030).
The applications of iliac stent procedures span a broad spectrum of vascular conditions, encompassing the management of peripheral artery disease (PAD), iliac artery aneurysms, traumatic injuries, and complex vascular pathologies. These procedures are commonly used to manage peripheral artery disease (PAD) affecting the iliac arteries. Plaque accumulation in the arteries, which results in decreased blood flow to the lower limbs, is a hallmark of PAD.
Iliac stenting can improve perfusion to the affected limb, promote wound healing, and reduce the risk of amputation in patients with advanced vascular disease. Additionally, these can treat iliac artery aneurysms, which are abnormal dilations or bulges in the iliac arteries. Stenting of iliac artery aneurysms can help prevent the risk of rupture, thrombosis, and embolization, particularly in high-risk patients or those with large or symptomatic aneurysms.
Saudi Arabia’s high healthcare costs reflect its dedication to providing its people with high-quality healthcare services. This includes investment in advanced medical technologies and infrastructure. According to the International Trade Administration data, Saudi Arabia contributes 60% of the healthcare expenditures of the Gulf Cooperation Council (GCC) nations, and the Saudi Arabian government continues to prioritize this sector. Thus, the expansion of the region’s healthcare sector is propelling the market’s growth.
Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA Iliac Stent Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $26.7 million by 2030. The Argentina market is showcasing a CAGR of 9.4% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 8.4% during (2023 - 2030).
The applications of iliac stent procedures span a broad spectrum of vascular conditions, encompassing the management of peripheral artery disease (PAD), iliac artery aneurysms, traumatic injuries, and complex vascular pathologies. These procedures are commonly used to manage peripheral artery disease (PAD) affecting the iliac arteries. Plaque accumulation in the arteries, which results in decreased blood flow to the lower limbs, is a hallmark of PAD.
Iliac stenting can improve perfusion to the affected limb, promote wound healing, and reduce the risk of amputation in patients with advanced vascular disease. Additionally, these can treat iliac artery aneurysms, which are abnormal dilations or bulges in the iliac arteries. Stenting of iliac artery aneurysms can help prevent the risk of rupture, thrombosis, and embolization, particularly in high-risk patients or those with large or symptomatic aneurysms.
Saudi Arabia’s high healthcare costs reflect its dedication to providing its people with high-quality healthcare services. This includes investment in advanced medical technologies and infrastructure. According to the International Trade Administration data, Saudi Arabia contributes 60% of the healthcare expenditures of the Gulf Cooperation Council (GCC) nations, and the Saudi Arabian government continues to prioritize this sector. Thus, the expansion of the region’s healthcare sector is propelling the market’s growth.
Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Becton, Dickinson and Company
- Abbott Laboratories
- Boston Scientific Corporation
- W.L. Gore & Associates, Inc.
- Medtronic PLC
- Cook Medical, Inc.(Cook Group)
- Terumo Corporation
- iVascular S.L.U.
- Getinge AB
- Biotronik SE & Co. KG
Market Report Segmentation
By Artery Lesions- Common Iliac Artery Lesions
- Severe Calcified Lesions
- Complete Obstructive Lesions
- Hospitals
- Outpatient Facilities
- Others
- Self-expandable Stents
- Balloon-expandable Stents
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Iliac Stent Market by Artery Lesions
Chapter 5. LAMEA Iliac Stent Market by End-use
Chapter 6. LAMEA Iliac Stent Market by Type
Chapter 7. LAMEA Iliac Stent Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Becton, Dickinson and Company
- Abbott Laboratories
- Boston Scientific Corporation
- W. L. Gore & Associates, Inc.
- Medtronic PLC
- Cook Medical, Inc.(Cook Group)
- Terumo Corporation
- iVascular S.L.U.
- Getinge AB
- Biotronik SE & Co. KG
Methodology
LOADING...
